AMBUJACEM

AMBUJACEM

12.01.2023 - JpMorgan on Ambujacem Maintain Neutral CMP 511 Target 490
29.12.2022 - Investec on Ambujacem Maintain Buy CMP 511 Target 752
25.10.2022 - Macquarie on Ambujacem Maintain Outperform CMP 526.65 Target 587
14.10.2022 - CITI on Ambujacem Maintain Sell CMP 502.15 Target 610
28.09.2022 - CLSA on Ambujacem Maintain Underperform CMP 506.75 Target 470
19.09.2022 - CITI on Ambujacem Maintain Sell CMP 563.2 Target 340
12.09.2022 - JpMorgan on Ambujacem Maintain Underweight CMP 475 Target 309
20.07.2022 - CS on Ambujacem Maintain Neutral CMP 367.35 Target 335
20.07.2022 - Jefferies on Ambujacem Maintain Hold CMP 367.35 Target 400
20.07.2022 - CITI on Ambujacem Maintain Sell CMP 367.35 Target 340
20.07.2022 - BOFA on Ambujacem Maintain Buy CMP 367.35 Target 410
12.07.2022 - CLSA on AMBUJACEM Maintain Underperform CMP 371 Target 375
29.04.2022 - BOFA on AMBUJACEM Maintain Buy CMP 383 Target 425
29.04.2022 - GS on AMBUJACEM Maintain Buy CMP 383 Target 390
13.04.2022 - CLSA on AMBUJACEM Maintain Buy CMP 365.1 Target 385
16.03.2022 - Jefferies on AMBUJACEM Maintain Buy CMP 295 Target 360
21.02.2022 - Jefferies on AMBUJACEM Maintain Buy CMP 338 Target 425
21.02.2022 - CLSA on AMBUJACEM Maintain Outperform CMP 338 Target 390
21.02.2022 - CITI on AMBUJACEM Maintain Downgrade Neutral CMP 338 Target 365
18.02.2022 - UBS on AMBUJACEM Maintain Neutral CMP 338.35 Target 420